Inventor
CARMELIET PETER
BE21 patents
⚠️ This page may combine multiple inventors who share the name “CARMELIET PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VLAAMS INTERUNIV INST BIOTECH
8 patentsUS7875704B2Jan 25, 2011
Anti-PLGF antibody
VLAAMS INTERUNIV INST BIOTECH8 citations83
US7482004B2Jan 27, 2009
Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage
VLAAMS INTERUNIV INST BIOTECH13 citations79
US8003096B2Aug 23, 2011
Means and methods for the recruitment and identification of stem cells
VLAAMS INTERUNIV INST BIOTECH10 citations76
US7307060B2Dec 11, 2007
Hypoxia inducible factor 2α for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension
VLAAMS INTERUNIV INST BIOTECH7 citations69
US7687463B2Mar 30, 2010
Treatment of amyotrophic lateral sclerosis
VLAAMS INTERUNIV INST BIOTECH2 citations62
US9085617B2Jul 21, 2015
Anti-angiogenic therapy
VLAAMS INTERUNIV INST BIOTECH0 citations51
US7863246B2Jan 4, 2011
Treatment of amyotrophic lateral sclerosis
VLAAMS INTERUNIV INST BIOTECH0 citations51
US7888322B2Feb 15, 2011
Use of VEGF and homologues to treat neuron disorders
VLAAMS INTERUNIV INST BIOTECH0 citations49
CARMELIET PETER
3 patentsUS9234025B2Jan 12, 2016
Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor
CARMELIET PETER0 citations45
US8741862B2Jun 3, 2014
PHD2 inhibition for blood vessel normalization, and uses thereof
CARMELIET PETER0 citations43
US10106601B2Oct 23, 2018
Inhibition of PLGF to treat philadelphia chromosome positive leukemia
CARMELIET PETER0 citations38